TrialESC heart failure2026

Phase 2b trial of an oral relaxin family peptide receptor 1 agonist in patients with chronic heart failure: rationale and design.

Macarena P Quintana-Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.